U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.2722T>C (p.Cys908Arg) AND Familial thoracic aortic aneurysm and aortic dissection

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 20, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002429487.2

Allele description [Variation Report for NM_000138.5(FBN1):c.2722T>C (p.Cys908Arg)]

NM_000138.5(FBN1):c.2722T>C (p.Cys908Arg)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.2722T>C (p.Cys908Arg)
HGVS:
  • NC_000015.10:g.48494210A>G
  • NG_008805.2:g.156579T>C
  • NM_000138.5:c.2722T>CMANE SELECT
  • NP_000129.3:p.Cys908Arg
  • NP_000129.3:p.Cys908Arg
  • LRG_778t1:c.2722T>C
  • LRG_778:g.156579T>C
  • LRG_778p1:p.Cys908Arg
  • NC_000015.9:g.48786407A>G
  • NM_000138.4:c.2722T>C
Protein change:
C908R
Links:
dbSNP: rs1060501021
NCBI 1000 Genomes Browser:
rs1060501021
Molecular consequence:
  • NM_000138.5:c.2722T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial thoracic aortic aneurysm and aortic dissection (TAAD)
Synonyms:
Thoracic aortic aneurysm and aortic dissection; Thoracic aortic aneurysms and dissections
Identifiers:
MONDO: MONDO:0019625; MedGen: C4707243; Orphanet: 91387; OMIM: PS607086

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002741464Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Mar 20, 2020)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.

Robinson PN, Booms P, Katzke S, Ladewig M, Neumann L, Palz M, Pregla R, Tiecke F, Rosenberg T.

Hum Mutat. 2002 Sep;20(3):153-61. Review.

PubMed [citation]
PMID:
12203987

TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.

Katzke S, Booms P, Tiecke F, Palz M, Pletschacher A, Türkmen S, Neumann LM, Pregla R, Leitner C, Schramm C, Lorenz P, Hagemeier C, Fuchs J, Skovby F, Rosenberg T, Robinson PN.

Hum Mutat. 2002 Sep;20(3):197-208.

PubMed [citation]
PMID:
12203992
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV002741464.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The p.C908R pathogenic mutation (also known as c.2722T>C), located in coding exon 22 of the FBN1 gene, results from a T to C substitution at nucleotide position 2722. The cysteine at codon 908 is replaced by arginine, an amino acid with highly dissimilar properties. The majority of FBN1 mutations identified to date have involved the substitution or generation of cysteine residues within cbEGF domains (Vollbrandt T et al. J Biol Chem. 2004;279(31):32924-32931). This variant has been detected in individuals with classic Marfan syndrome and with Marfan-like findings (Katzke S et al. Hum. Mutat., 2002 Sep;20:197-208; Stheneur C et al. Eur. J. Hum. Genet., 2009 Sep;17:1121-8; Khan AO et al. J AAPOS, 2014 Apr;18:134-9). Based on internal structural assessment, this alteration eliminates a structurally critical disulfide in the structurally sensitive hybrid motif #02 domain. Furthermore, alternate amino acid substitutions at this codon, p.C908Y and p.C908G, have also been reported in Marfan syndrome cohorts, suggesting this as a hotspot position (Judge DP et al. Am J Med Genet. 2001;99:39-47; Wang WJ et al. J Mol Med. 2013;91:37-47; Haine E et al. J Bone Miner Res. 2015;30:1369-76). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024